title: Syntaxin 1A inhibits CFTR chloride channels by means of domain-specific protein-protein interactions.
abstract: Previously we showed that the functional activity of the epithelial chloride channel that is encoded by the cystic fibrosis gene (CFTR) is reciprocally modulated by two components of the vesicle fusion machinery, syntaxin 1A and Munc-18. Here we report that syntaxin 1A inhibits CFTR chloride channels by means of direct and domain-specific protein-protein interactions. Syntaxin 1A stoichiometrically binds to the N-terminal cytoplasmic tail of CFTR, and this binding is blocked by Munc-18. The modulation of CFTR currents by syntaxin 1A is eliminated either by deletion of this tail or by injecting this tail as a blocking peptide into coexpressing Xenopus oocytes. The CFTR binding site on syntaxin 1A maps to the third predicted helical domain (H3) of this membrane protein. Moreover, CFTR Cl- currents are effectively inhibited by a minimal syntaxin 1A construct (i.e., the membrane-anchored H3 domain) that cannot fully substitute for wild-type syntaxin 1A in membrane fusion reactions. We also show that syntaxin 1A binds to and inhibits the activities of disease-associated mutants of CFTR, and that the chloride current activity of recombinant DeltaF508 CFTR (i.e., the most common cystic fibrosis mutant) can be potentiated by disrupting its interaction with syntaxin 1A in cultured epithelial cells. Our results provide evidence for a direct physical interaction between CFTR and syntaxin 1A that limits the functional activities of normal and disease-associated forms of this chloride channel.
authors.affiliation: Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.
authors.forename: A P
authors.initials: AP
authors.lastname: Naren
authors.forename: M W
authors.initials: MW
authors.lastname: Quick
authors.forename: J F
authors.initials: JF
authors.lastname: Collawn
authors.forename: D J
authors.initials: DJ
authors.lastname: Nelson
authors.forename: K L
authors.initials: KL
authors.lastname: Kirk
mesh_terms: D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism / Q000502:physiology*; D019556:COS Cells; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D018374:LLC-PK1 Cells; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000378:metabolism / Q000502:physiology*; D011485:Protein Binding; D013552:Swine; D050827:Syntaxin 1; D014981:Xenopus
chemical_list: D000954:Antigens, Surface; C505032:CFTR protein, human; D009419:Nerve Tissue Proteins; C494212:STX1A protein, human; D050827:Syntaxin 1; D019005:Cystic Fibrosis Transmembrane Conductance Regulator